ResMed Inc. (RMD.AX) Financials

RMD.AX Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 12.7 billion 3.3 billion
Sept. 30, 2025 12.6 billion 3.3 billion
June 30, 2025 12.4 billion 3.4 billion
March 31, 2025 12.1 billion 3.2 billion

RMD.AX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 475.9 million 43.3 million
Sept. 30, 2025 626.8 million 32.0 million
June 30, 2025 767.9 million 37.6 million
March 31, 2025 887.6 million 38.6 million

RMD.AX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 597.5 million
Sept. 30, 2025 527.2 million
June 30, 2025 577.4 million
March 31, 2025 584.0 million

RMD.AX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 2.1 billion 836.1 million 230.9 million
Sept. 30, 2025 2.1 billion 618.2 million 269.0 million
June 30, 2025 1.8 billion 1.0 billion 279.1 million
March 31, 2025 1.5 billion 1.1 billion 266.7 million

RMD.AX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 2.2 billion
Sept. 30, 2025 2.2 billion
June 30, 2025 2.2 billion
March 31, 2025 2.4 billion

RMD.AX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 43.6 million 138.4 million 419.6 million -
Sept. 30, 2025 65.0 million 132.1 million 392.1 million -
June 30, 2025 51.4 million 131.5 million 403.2 million -
March 31, 2025 38.1 million 134.3 million 392.4 million -

RMD.AX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 2.2 billion 845.9 million
Sept. 30, 2025 2.0 billion 778.7 million
June 30, 2025 2.0 billion 802.8 million
March 31, 2025 2.1 billion 840.4 million

RMD.AX

Price: A$27.64

52 week price:
25.84
45.25

Dividend Yield: 7.41%

5-year range yield:
0.99%
7.41%

Payout Ratio: 47.59%

Payout Ratio Range:
-72.31%
523.30%

Earnings Per Share: 1.41 AUD

P/E Ratio: 21.80

Exchange: ASX

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Market Capitalization: 44.8 billion

Average Dividend Frequency: 6

Years Paying Dividends: 15

DGR3: 26.13%

DGR5: 18.76%

DGR10: 12.32%

Links: